secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001437749-25-021153
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology amends bylaws to align with Delaware law updates
-------------------------------------------------------------------

- Board adopted Fifth Amended and Restated Bylaws on June 19, 2025.
- Changes primarily reflect updates to Delaware General Corporation Law.
- Includes conforming, ministerial, and other related revisions.
- No substantive operational or financial changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774925021153/0001437749-25-021153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774925021153/pbyi20250620_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-021153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer